CDMOs offering Quality Control Testing with Small Molecule
69 published
69 published CDMOs match Quality Control Testing and Small Molecule.
Locations in this set include United States, India, United Kingdom, Canada, France, and Germany.
Capabilities that show up most often in this set: CMC Analytical Development, Process Development, CMC Regulatory Submission Support, Formulation Development, and Technology Transfer.
Matching companies
Sai Life SciencesIntegrated CRDMO offering discovery, development, and manufacturing services for small molecule NCE programs across 280+ global pharma and biotech clients.
Siegfried HoldingGlobal CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.
Simtra BioPharma SolutionsSimtra BioPharma Solutions is a CDMO specializing in sterile injectable development and manufacturing, including formulation, lyophilization, fill/finish, and bioconjugation services for clinical and commercial products.
Stason Industrial CorporationUS-based CDMO offering contract packaging, analytical testing, and manufacturing services for clinical trial and commercial pharmaceutical production, with specialized high-containment capabilities for potent compounds.
Sterling Pharma SolutionsSmall molecule CDMO offering comprehensive API development and manufacturing from discovery through commercial cGMP production, with specialized expertise in complex and hazardous chemistries and ADC bioconjugation.
Sussex Research Laboratories Inc.Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.
Symbiosis Pharmaceutical ServicesUK-based fill-finish CDMO offering rapid access to GMP aseptic manufacturing for clinical and commercial injectable drug products across mAbs, ATMPs, ADCs, RNA, peptides, vaccines, and small molecules.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
UPM PharmaceuticalsIndependent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized.
Markdown mirror: /explore/quality-control-testing/small-molecule.md